Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

avivagen announces tsx venture exchange approval for extension of warrants

Sumary of Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants:

  • Avivagen previously announced its intention to seek approval of such extension by way of a press release on June 7, 2021..
  • Avivagen OxC-beta™ technology is derived from Avivagen discoveries about β-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours..
  • OxC-beta™ Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds..
  • The product is currently available for sale in the United States, Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia and Malaysia..
  • Article content Avivagen OxC-beta™ Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters..
  • Numerous international livestock trials with poultry and swine using OxC-beta™ Livestock have proven that the product performs as well as, and, sometimes, in some aspects, better than in-feed antibiotics….

Want to know more click here go to source.

From -
Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close